Clinical Trial Update: Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™. [NA]

View source ↗

Summary

Early feasibility clinical trial update for the TriAlign Percutaneous Tricuspid Valve Annuloplasty System by Mitralign, evaluating treatment of functional tricu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Tricuspid Regurgitation
• Heart Valve Disease
• Tricuspid Valve Insufficiency

Drugs mentioned

• TriAlign Percutaneous Tricuspid Valve Annuloplasty System

Snippet

Sponsor: Mitralign, Inc. | Conditions: Chronic Symptomatic Functional Tricuspid Regurgitation, Tricuspid Valve Insufficiency | NA | Status: UNKNOWN